Clinical Trial

Steroid Diabetes in Patients With Kidney Disease

Recruiting
View on ClinicalTrials.gov →
Summary
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-07.
Status change: Not Yet Recruiting → Recruiting 2024-04-25
Trial Details
NCT Number NCT06161701
Lead Sponsor Zhejiang Provincial People's Hospital
Collaborators: The Third Affiliated Hospital of Wenzhou Medical University, The First People's Hospital of Xiaoshan District, Hangzhou City, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Nanxun District People's Hospital of Huzhou City,China, Wenling Traditional Chinese Medicine Hospital, Affiliated Hospital of Jiaxing University, Taizhou Hospital, The First People's Hospital of Chun'an
Conditions Nephrotic Syndrome
Enrollment 300 participants
Start Date 2024-01-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-04-29